Please login to the form below
Autolus
This page shows the latest Autolus news and features for those working in and with pharma, biotech and healthcare.
Bicycle Therapeutics looks to raise $86m with IPO
In November last year, gene therapy specialist Orchard Therapeutics raised over $200m, while CAR-T biotech Autolus generated $150m from its IPO in June.
Latest news
-
CAR-T player Autolus seeks $100m from follow-on financing
After a $100m initial public offering last year, Autolus is sitting on upwards of $200m ahead of the follow-on financing. ... to raise additional capital in order to develop and commercialize our product candidates,” said Autolus in an filing with the
-
Autolus’ next-gen CAR-T looks promising in ALL
Safety profile could bring greater market potential. UK biotech Autolus seems to be on track to develop a next generation of safer and equally, if not more, efficacious CAR-T therapies. ... Autolus is hoping that AUTO1 will change that, and its first
-
Novartis and Syncona back new Swiss biotech Anaveon
Autolus, which raised $150m in its IPO last June.
-
UK biotech booms in 2018, despite Brexit worries
Industry attracted a record-breaking £2.2bn in investment last year
-
UK’s genomics leadership attracts IQVIA investment, regardless of Brexit
Roche, Celgene and Autolus.
More from news
Approximately 5 fully matching, plus 9 partially matching documents found.
Latest appointments
-
Former Roche development head joins Asana advisory board
The founder of KAPital Consulting, Dr Dhingra currently serves on the boards of Exosome Diagnostics as chairman of the board, Advanced Accelerator Applications, Five Prime and Autolus.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Understanding the evolving CAR-T market
More than 500 CAR-Ts are in development, making competition fierce. Earlier this year Autolus was forced to delay and even discontinue molecules in its CAR-T pipeline due to both ... The clinical data readout for the AUTO5 trial showed that it “may not
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- FDA approves Roche’s Actemra COVID-19 trial
- Roche’s Ocrevus boasts positive long-term data in MS
- First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
